GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » ROIC %

3B BlackBio Dx (BOM:532067) ROIC % : 16.20% (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. 3B BlackBio Dx's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was 16.20%.

As of today (2024-05-17), 3B BlackBio Dx's WACC % is 8.92%. 3B BlackBio Dx's ROIC % is 13.56% (calculated using TTM income statement data). 3B BlackBio Dx generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


3B BlackBio Dx ROIC % Historical Data

The historical data trend for 3B BlackBio Dx's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx ROIC % Chart

3B BlackBio Dx Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.51 22.03 118.85 17.13 13.33

3B BlackBio Dx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.26 11.91 12.94 13.84 16.20

Competitive Comparison of 3B BlackBio Dx's ROIC %

For the Biotechnology subindustry, 3B BlackBio Dx's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3B BlackBio Dx's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's ROIC % distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's ROIC % falls into.



3B BlackBio Dx ROIC % Calculation

3B BlackBio Dx's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Mar. 2023 is calculated as:

ROIC % (A: Mar. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2022 ) + Invested Capital (A: Mar. 2023 ))/ count )
=282.817 * ( 1 - 26.54% )/( (1604.138 + 1514.114)/ 2 )
=207.7573682/1559.126
=13.33 %

where

Invested Capital(A: Mar. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1920.914 - 43.879 - ( 272.897 - max(0, 169.008 - 815.403+272.897))
=1604.138

Invested Capital(A: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2140.586 - 41.998 - ( 584.474 - max(0, 141.838 - 1142.364+584.474))
=1514.114

3B BlackBio Dx's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=342.112 * ( 1 - 23.63% )/( (1612.968 + 0)/ 1 )
=261.2709344/1612.968
=16.20 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2249.207 - 37.96 - ( 598.279 - max(0, 102.059 - 1214.078+598.279))
=1612.968

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx  (BOM:532067) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, 3B BlackBio Dx's WACC % is 8.92%. 3B BlackBio Dx's ROIC % is 13.56% (calculated using TTM income statement data). 3B BlackBio Dx generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases. 3B BlackBio Dx earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


3B BlackBio Dx ROIC % Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines